Home > Products > BAFF & IL17
> Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (scDiabody-CH3)
Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (scDiabody-CH3) (CAT#: SCDBC-019)
Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (scDiabody-CH3) is a fusion protein of two scDiabodies connected together by a CH3 region. In single-chain Diabodies, an additional connecting linker is introduced between chains of the anti-BAFF/anti-IL17 diabody. The scDiabody with two specificities is fused to each of the CH3 chains to extend half-life. This BsAb can neutralize both BAFF and IL- 17 simultaneously. It is designed for the research of Lupus Nephritis (LN); Systemic Lupus Erythematosus (SLE); Rheumatoid Arthritis (RA); Psoriasis (Ps); Ankylosing Spondylitis (AS); Psoriatic Arthritis (PA) primary Sjögren's Syndrome (pSS); Multiple Myeloma (MM) therapy.
There are currently no customer reviews or questions for Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (scDiabody-CH3) (SCDBC-019). Click the button below to contact us or submit your feedback about this product.